Martina Flammer - Sep 12, 2024 Form 4 Insider Report for INSMED Inc (INSM)

Role
Chief Medical Officer
Signature
/s/ Martina Flammer, M.D., by Michael A. Smith as Attorney-in-fact
Stock symbol
INSM
Transactions as of
Sep 12, 2024
Transactions value $
-$1,677,586
Form type
4
Date filed
9/16/2024, 04:46 PM
Previous filing
Sep 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSM Common Stock Options Exercise $21.6K +635 +0.6% $34.03 107K Sep 12, 2024 Direct F1
transaction INSM Common Stock Sale -$47.6K -635 -0.59% $74.92 106K Sep 12, 2024 Direct F1, F2
transaction INSM Common Stock Options Exercise $918K +27K +25.41% $34.03 133K Sep 13, 2024 Direct F1
transaction INSM Common Stock Sale -$2.02M -27K -20.26% $74.90 106K Sep 13, 2024 Direct F1
transaction INSM Common Stock Options Exercise $457K +13.4K +12.66% $34.03 120K Sep 16, 2024 Direct F1
transaction INSM Common Stock Sale -$1.01M -13.4K -11.24% $74.92 106K Sep 16, 2024 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSM Stock Option (right to buy) Options Exercise $0 -635 -1.16% $0.00 54.1K Sep 12, 2024 Common Stock 635 $34.03 Direct F1, F4
transaction INSM Stock Option (right to buy) Options Exercise $0 -27K -49.86% $0.00 27.1K Sep 13, 2024 Common Stock 27K $34.03 Direct F1, F4
transaction INSM Stock Option (right to buy) Options Exercise $0 -13.4K -49.55% $0.00 13.7K Sep 16, 2024 Common Stock 13.4K $34.03 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2 This is the weighted average sales price representing 635 shares sold at prices ranging from $74.90 to $74.93 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3 This is the weighted average sales price representing 13,436 shares sold at prices ranging from $74.90 to $75.17 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F4 The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.